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Complying with ethical principles in elderly and frail 
patients with advanced chronic kidney disease
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 Abstract
Introduction: In 2016, in Europe (EU), 27.3 million people were aged > 80 (the so-called “elderly 
people”), and this value will likely increase up to 7 million more in ten years time. Portugal 
follows that world trend and has presently the fifth highest proportion of elderly people in the 
EU. According to the data records from the Portuguese Society of Nephrology, the cohort of 
dialysis patients aged > 80 years appears in the tables as an individualized group with a significant and increasing prevalence since 
2015. Overtreatment of elderly patients ESRD has gained attention in professional journals and the lay mediafueled by disturbing 
outcome data. Therefore, it is imperative to review the application of dialysis treatment. Patients should be informed about the 
options of treatment, including the more conservative, non-dialytic ones and the implications of the different options for their lives.
Aims: To analyze ethically the problems faced in renal replacement therapy resulting from the aging of the population in Portugal.
Materials and methods: A critical review and analysis was conducted to discuss the dilemmas and challenges to deal with the 
above critical situation, namely the approach dialysis versus conservative treatments.
Results: The basis for all processes involved are, namely: (i) the ethics´ principles that are the key support to guide the care 
providers through the treatment options; (ii) the estimation of prognosis and shared decision-making and (iii) the palliative care, 
which is an area where the awareness of clinicians needs to be urgently improved. 
Conclusions: It is crucial the presentation to the patients of the several options of treatment aiming to achieve a better balance 
between risks and benefits and the best possible response to the goals and expectations of the patients.
 Resumo
Introdução: Na Europa (EU), em 2016, 27,3 milhões de pessoas apresentavam mais de 80 
anos de idade (os denominados pessoas muito idosas), número com tendência para aumentar 
em sete milhões no espaço de 10 anos. Portugal acompanha esta tendência e é, atualmente, o 
5.º país da EU com a maior proporção de pessoas idosas. De acordo com dados da Sociedade 
Portuguesa de Nefrologia, a proporção de doentes em diálise nestas faixas etárias tem aumentado significativamente desde 2015. 
O sobretratamento dos idosos com Insuficiência renal crónica em estádio terminal tem ganho atenção nas publicações científicas 
médicas, tendo em conta os resultados obtidos. Deste modo, é imperativo rever a introdução/continuação dos tratamentos de 
diálise nesta população. Os doentes devem ser informados acerca das diferentes opções terapêuticas, nelas incluindo cada vez 
mais as mais conservativas, não dialíticas, assim como as implicações que cada opção terá na sua vida.
Objetivos: Analisar eticamente os problemas do processo de tomada de decisão perante a terapêutica de substituição renal na 
população idosa em Portugal.
Materiais e métodos: Realizar uma revisão e análise crítica para discutir os dilemas éticos no processo de decisão destas 
situações, nomeadamente a opção entre diálise e tratamento conservador.
Resultados: As bases de todos os processos envolvidos são, nomeadamente: (i) os princípios éticos, que constituem um suporte 
fundamental para guiar os profissionais de saúde através das várias opções de tratamento; (ii) a estimativa de prognóstico e a 
formulação de uma decisão partilhada e (iii) os cuidados paliativos, área em que a consciencialização dos profissionais de saúde 
precisa urgentemente de ser melhorada.
Conclusões: É crucial a apresentação aos doentes das várias opções de tratamento, por forma a conseguir um bom equilíbrio 
entre riscos e benefícios e dar a melhor resposta possível aos objetivos e expectativas dos mesmos.
Keywords
Ethical principles; Palliative 




dos paliativos; tratamento 
renal conservador.
45C o m p l y i n g  w i t h  e t h i ca l  p r i n c i p l e s  i n  e l d e r l y  a n d  f ra i l  p a t i e n t s  w i t h  a d va n ce d  c h r o n i c  k i d n e y  d i s e a s e  
I don't know what awaits us but I know 
what worries me: is that medicine, excited by 
science, seduced by technology and stunned 
by bureaucracy, erases her human face and 
ignores the unique individuality of each per-
son who suffers, because although more and 
more ways to treat are invented, it has not 
yet been discovered how to relieve suffering 
without empathy or compassion.
João Lobo Antunes (a portuguese neurosurgeon), 
A Nona Medicina
 Introduction
The world’s population is aging rapidly.1 In 2016, 
in Europe (EU), 27.3 million people were aged > 
80 (the so-called “elderly people”), and this value 
will likely increase up to 7 million more in ten 
years time. Portugal follows that world trend and 
has presently the fifth highest proportion of elderly 
people in the EU.2
Following the above scenario, diseases such as 
diabetes mellitus and systemic arterial hypertension 
became more prevalent, and the risk of patients 
developing chronic kidney disease increased, leading 
to the rising prevalence of old and frail patients 
on dialysis.
In Portugal, when dialysis units were first 
established in the seventies, dialysis was restricted 
to younger and fitter patients. That situation changed 
dramatically over the years, and all the indicators 
such as number, age, and comorbidity of the patients 
rose significantly. According to the data records from 
the Portuguese Society of Nephrology, the cohort 
of dialysis patients aged > 80 years appears in the 
tables as an individualized group with a significant 
and increasing prevalence since 2015.
In 2018, among the 12227 patients on hemodialysis 
(HD) in Portugal, more than 2700 (22%) are in the 
age group > 80 years. That group accounted for 
578 new HD starts in 2018 (almost 25% of the new 
starts).3 
Following the international tendency, in Portugal, 
there is a continuous and significant increase in the 
number of patients with end-stage renal disease 
(ESRD), who besides that, have multiple severe 
conditions and display high mortality and morbidity 
rates. The leading causes of this situation are related 
to cardiovascular diseases, infections, dialysis 
vascular access problems, as well as prolonged and 
frequent hospitalizations.4,5 Presently HD is offered 
as the primary life-prolonging therapy overcoming 
the conservative treatments for ESRD.6,7
The accumulated experience indicates that 
the benefits of dialysis are modest in specific 
populations.8-10 Overtreatment of elderly patients 
ESRD has gained attention in professional journals11,12 
and the lay media13 fueled by disturbing outcome 
data.14-16 Therefore, it is imperative to review the 
application of dialysis treatment. Patients should be 
informed about the options of treatment, including 
the more conservative, non-dialytic ones and the 
implications of the different options for their lives. 
The challenge for the healthcare providers and 
in particular for nephrologists is to balance the 
benefits and adverse effects of dialysis, bearing 
in mind the cardinal ethical questions (respect 
for autonomy, beneficence, nonmaleficence, and 
justice). One key aspect for care providers is to 
be able to help patients to make decisions about 
the options presented by the clinicians according 
to their goals and expectations in life.
First steps are being taken in Portugal; for example, 
public hospitals offer now outpatient consultation 
for conservative renal treatment. Also, there are 
increasing efforts from the nephrologist community 
in acquiring skills in communication with patients 
and palliative care, and the trend is to increase the 
number of palliative care unities significantly both 
in hospitals (public and private) and for outpatients.
 Materials and methods
In this paper, we address the challenges to deal 
with renal treatment in line with ethical questions 
and consider ways in which care providers can 
approach the issue of dialysis versus conservative 
treatments in the elderly and frail patients.
Prospective controlled studies demonstrate that 
for a patient aged >75 years with comorbidities 
(especially ischemic heart disease), dialysis seems 
not to offer a survival advantage over conservative 
management (CM). Also, with the initiation of 
dialysis, the quality of life deteriorates and does 
not recover. While the CM patients maintain a stable 
quality of life until typically one or two months 
before their demise.9,17,18 Moreover, some patients 
do not tolerate in-center hemodialysis well and 
have a suboptimal quality of life, or even suffer 
harm from the treatment.19 Qualitative studies have 
uncovered a significant symptom and treatment 
burden associated with HD.20-22 One example is 
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functional status and independence that is a most 
important issue for elderly patients16,24,25 and is rapidly 
lost after HD is initiated.
First-year mortality for incident dialysis patients, 
by age group, is 26.7% for patients aged 70-79 years, 
34.6% for 80-84 years, and 40.4% for > 85 years. 
As many as 35% of the elderly patients discontinue 
dialysis.26 Compared with non-dialytic conservative 
management, elderly patients who undergo dialysis 
can expect to spend more of their remaining life 
years in dialysis units or hospitals and are 2 to 3 
times more likely to die in the hospital.27
Taking into account the above reasons it is 
important not to rush to initiating dialysis. Several 
recent studies have highlighted the lack of benefit 
and potential harm from earlier initiation of dialysis, 
and this also pertains to the elderly patient 28-30. Frailty 
increases the risk of early start of dialysis31,32 Canadian 
guidelines nowadays recommend intention-to-defer 
dialysis.29 This is especially important for the oldest 
patients because one-third of octogenarians with 
advanced CKD do not progress to ESRD and require 
only observation and conservative management.32 
This is in line with increasing evidence obtained 
during the past decade, which suggests that the 
overall benefit of dialysis is modest for specific 
populations, in particular frail, elderly patients with 
multimorbidity. 
Ethical principles should be considered in all health 
care decisions. They aim at respecting autonomy, 
beneficence, nonmaleficence, and justice.33 Ethical 
decisions should be based on the understanding 
by the patients of the goals of treatment, risks, 
and benefits and considering their values and 
preferences.34
Decision making in dialysis often involves ethical 
dilemmas such as an example: is dialysis the most 
appropriate treatment for the individual patient? 
When the decisions are difficult, ethics provides 
a structure, a guide of thinking that gives moral 
comfort and support for the care providers finding 
the right things to do.
In many countries, respect for the patient’s 
autonomy is the most important of the four ethical 
principles. Autonomy is particularly relevant when 
different principles are in conflict and the balance 
between beneficence and nonmaleficence is complex 
and delicate.35,36 Respect for patient autonomy 
means offering the patient the possibility to hold 
his views and to make choices among the options 
presented by the clinicians. Ideally, the discussions 
with patients should begin well before the need 
for dialysis is urgent, so that patients have time to 
think carefully about their goals for care, values, 
and preferences. 
According to Kaldjian et al., six goals should 
be explored with patients facing CKD. They are: 
(i) Be cured; (ii) Live longer; (iii) Improve or 
maintain function/quality of life/ independence; 
(iv) Be comfortable; (v) Achieve life goals; (vi) 
Provide support for family/caregiver to allow them 
to articulate the treatments that will help them to 
accomplish their goals.37 
The information about the kidney disease 
prognosis and the renal replacement options must 
be forwarded to the patients in due time and in such 
a clear way that they can understand the options 
and the likely implications of their choices. There 
are several factors that can decrease the quality of 
the patients’ decision and its implementation, namely 
(i) poor or not well-explained information about the 
treatment options; (ii) timing and expected benefits 
of dialysis; (iii) insufficient time for decision making; 
(iv) limited or no existing resources; (v) influence 
of colleagues and family and (vi) reluctance to 
deviate from the status quo.38.
Indeed, most patients (dialysis-dependent or not) 
are willing to engage in end-of-life discussions 
and desire some form of advance directive. These 
documents (written or oral) are conceived and 
legitimated as enactments of the principle of “patient 
autonomy”. They emphasize individuals being in 
control of their own life, even in cases of future 
severely incapacitating illnesses or loss of mental 
faculties, which preclude their capacity to make 
choices. They may also work as an “icebreaker”, 
allowing it easier for healthcare professionals 
and relatives to communicate about the patient’s 
preferences and interests. It is not by chance that a 
randomized controlled study concluded that advance 
care planning, including the formulation of an 
advance directive “improves end of life care and 
patient as well as family satisfaction reducing stress, 
anxiety, and depression in the loved ones”.39 
According to surveys and interviews of patients 
undergoing hemodialysis, it seems that most patients 
feel that the information given to them on their 
ESRD and hemodialysis or other viable choices is 
not enough.40-42
One crucial aspect of being considered is the 
capacity of the patients to make an informed 
decision about dialysis starting or continuation. 
Indeed, increasing evidence indicates that a 
significant proportion of patients in the pre-dialysis 
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setting and currently on dialysis may lack that 
capacity.43
In line with the ethical principle of beneficence, all 
clinicians (including nephrologists), have the moral 
obligation to act for the benefit of the patient. This 
includes carefully balancing treatment´s benefits and 
burdens (such as dialysis), and to communicate 
their recommendations to the patient and his family. 
However, the wishes of the patient and family, 
although should be considered, should not, taken 
alone, be determinative of the final decision.
Also, according to the principle of nonmaleficence, 
health providers should not recommend 
potentially harmful treatments with few chances of 
benefit. Therefore, it must be born in mind that HD 
may do more harm than good for some of the frail 
elderly patients. The experience in nursing homes 
and community-dwelling elders, suggests that the 
onset of HD may bring rapid functional decline.24,25 
Many older HD patients regret having started HD.41,44 
The symptom burden in the elderly HD patient is 
heavy and approximates to that of cancer.14 In these 
cases, palliative care can significantly alleviate the 
situation (even in patients who withdraw from HD), 
but it is unfortunately underutilized.
Similarly, elderly patients with dementia have 
particularly poor survival on HD. Disruption in 
their routine such as caused by HD treatment, can 
trigger fear and agitation leading to rapid functional 
decline.45
The ethical principle of justice implies the just 
and equitable distribution of health resources such 
as dialysis and the set of resources required when 
conservative management is adopted. Regarding 
conservative management, a study focused on 
the experiences of patients opting not to have 
dialysis or withdrawing from dialysis, showed that 
one problem felt by the patients was the sense of 
abandonment due to little follow-up care after their 
decision.46 This raises the importance of an ethical 
approach to these patients, which should include 
palliative support and awareness and education of 
nephrologists in this dimension of care.
To summarize, health providers and in particular 
nephrologists must face significant challenges to 
guide the elderly and frail renal patients with 
multimorbidity through the treatment options that 
best fit their medical condition supported by the four 
ethical principles and taking into account the goals 
and expectations of the patients and their families.
 Resulting considerations
Our review analysis points out to several resulting 
considerations, as follows. Providing ethical multicare 
solutions for elderly and frail renal patients with 
multimorbidity put significant challenges on the care 
providers. These challenges became more acute 
along the years, mainly due to population aging. This 
situation creates a huge impact on the health care 
system in view of: (i) the limited health resources; 
(ii) the low effectiveness in the elderly group of 
population of more intrusive treatments such as 
dialysis and (iv) the little practice of conservative 
treatments leading to insufficient development of 
palliative care, which requires specific knowledge 
and supportive structures.
 Limitations and recomendations
The first step to improve the situation is to 
develop methodologies to select the more suitable 
and ethical option for the patient, preferably via 
a process of shared decision-making (SDM). This 
is the recommended model for dialysis decision-
making because it heads the need for ethical 
considerations, to entirely inform patients about the 
risks and benefits of dialysis, as well as the need 
to guarantee that patients’ values and preferences 
play a leading role.47
SDM guideline established limits in the SDM 
process. These limits were set to protect the rights 
of patients and the professional integrity of health 
professionals. In the ethical structure of SDM, the 
patient has the right to deny dialysis even if the 
nephrologist disagrees with the patient’s decision. 
Likewise, the nephrologist has the right to decline 
to offer dialysis when the foreseen benefits do 
not justify the risks. Acknowledging that there are 
situations in which patients and nephrologists might 
disagree about the decisions to start, continue, 
or withdraw dialysis. The guidelines of SDM 
stipulates recommendations of how to resolve such 
challenges by comprising the use of time-limited 
trials and ethics counseling.
Shared Decision aids to improve patients’ 
knowledge of their options, give them realistic 
expectations of benefits and harms and helps to 
make choices concordant with the patient’s values 
and goals of care. Several studies show that 
patients undergoing dialysis are eager to have more 
information.48,49 Discussing options with patients 
is crucial, but it is critically important to avoid 
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presenting treatment options as “Do hemodialysis 
or do ‘nothing” or even worse as “Do hemodialysis 
or die.” The full spectrum of treatment options 
should be on the table when discussing options 
with patients. For seriously ill patients, clinicians 
must be prepared to face patients’ decisions that 
may be modulated by interferences from family 
members, which can be biased by an irrealistic 
optimism motivated by the nonacceptance of losing 
their loved ones.
Presently, many nephrologists and nephrology 
fellows feel poorly prepared to address those 
challenging discussions.50,51 
Specific clinical training, especially in 
communication with the patient, is urgently needed. 
Among the goals is, for example, to develop 
alternatives to present ambiguous medical terms 
to ensure that the patient understands as clear as 
possible the treatment options and the associated 
risks and benefits. Providers should also be prepared 
to address patient misunderstanding and to cope 
with their emotional responses.
Communication can be further complicated or 
jeopardized by the low health literacy of the patient. 
This may even impede the patient’s capability to 
understand medical concepts. Therefore, clinicians 
should develop skills (especially for older patients) 
to explain to the patient his prognosis and treatment 
options in more straightforward terms and make 
sure by cross-questioning that the patient got the 
most essential part of the message.
Concerning palliative care services, there is an 
increasing awareness of nephrologists and health 
systems of the importance of being able to provide 
end-of-life care to these patients.52 Nephrologists 
should get familiarized with palliative services and 
consider palliative care as part of their professional 
responsibilities.
The term palliative dialysis starts to be used to 
indicate a form of patient-centered dialysis that is 
focused on the patient’s quality of life.
Dialysis promotes an extension of life but requires 
an increased burden of four hours of tri-weekly 
hemodialysis treatments, which may result in an 
unacceptable decrease in the quality of life of old 
and sick people.23 However, dialysis can be adapted 
to the patient’s needs and wishes and need not be 
“a prison”.
However, there is still no agreement on the 
definition and establishment of “incremental” dialysis 
as a regular procedure. Some changes are being 
considered, for example, U.S. experts suggest an 
approach based on twice-weekly dialysis, and in 
Italy, where it is often part of an integrated approach 
which includes nutritional management, dialysis 
start involves typically one session per week, while 
continuing the diet prescribed in the pre-dialysis 
phase (usually with a moderate protein restriction, 
at 0.6–0.8 g/Kg/day).53-57 
 Conclusions
Although dialysis is, without any doubt, a valuable 
and life-extending treatment which has enabled 
thousands of old patients with ESRD to live longer 
with improved quality of life, current evidence does 
not support the moral and technological imperative 
to dialyze all elderly patients with ESRD- irrespective 
of their comorbidity and functional status.
Therefore, treatment options that best suit the 
patient’s goals should be presented by the care 
providers. Shared decision-making should be 
implemented as it fulfills the ethical principles of 
autonomy, beneficence, and non-maleficence, which 
are a vital support to guide the options of treatment. 
Unlike standardized medicine aiming to achieve 
the best medical solution, in an ethical discussion, 
there is no medical best solution. Instead, the goal 
is to reach a personalized choice adapted to the 
individual´s context.
Indeed, there is room and an urgent need for 
“personalized medicine” in renal replacement 
therapy such as it happens already in chemotherapy, 
where protocols are increasingly being adapted to 
the patients.
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